Patient perspectives of dabigatran: analysis of online discussion forums.

  title={Patient perspectives of dabigatran: analysis of online discussion forums.},
  author={Mary Vaughan Sarrazin and Peter Cram and Alexandur Mazur and Melissa M Ward and Heather S. Reisinger},
  journal={The patient},
  volume={7 1},
BACKGROUND In 2010 the US FDA approved dabigatran, the first new anticoagulant for stroke prevention in non-valvular atrial fibrillation (AF) since 1954. To date there is little data that reflects the experiences and perceptions of real-world patients with dabigatran. The abundance of Internet-based discussion forums and support groups related to AF or anticoagulation may provide a low-cost resource for assessing patient experiences. OBJECTIVE The aim of this study was to determine patient… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 15 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…